In Memoriam:
Dr. Thomas Lehner,
Pioneer in Neuropsychiatric Disease Research
In honor of Dr. Lehner’s determination to unravel the complexities of the human brain and develop innovative treatments for neuropsychiatric disorders, the New York Genome Center has established the Thomas Lehner Fund for Neurospychiatric Disease Genomics to continue his legacy. Thank you for your support.